“The combination of CDP-choline , an α7 nicotinic acetylcholine receptor (α7 nAChR) agonist, with galantamine , a positive allosteric modulator of nAChRs, is believed to counter the fast desensitization rate of the α7 nAChRs and may be of interest for schizophrenia (SCZ) patients.”